Immunotherapy-Based Combinations for Advanced NSCLC: Unmet Needs and New Excitement
Did you know that new immunotherapy-based combinations are emerging for the treatment of advanced non-small cell lung cancer (NSCLC)?
All Credits Available
PhysiciansMaximum of 0.25 AMA PRA Category 1 Credit(s)™
ABIM DiplomatesMaximum of 0.25 ABIM MOC points
Target Audience and Goal Statement
This educational activity is intended for an international audience of non-US oncologists, pulmonologists, pathologists, and the oncology care team.
The goal of this activity is for learners to be better able to identify and discuss new clinical data and insights on immunotherapies for advanced NSCLC prior to the World Conference on Lung Cancer (WCLC) 2023.
Upon completion of this activity, participants will:
- Have increased knowledge regarding the
- Rationale for combining anti-programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) with anti-cytotoxic T-lymphocyte-associated antigen (CTLA-4) therapies for the treatment of NSCLC
- Latest clinical data for immunotherapy combinations for metastatic NSCLC
- Demonstrate greater confidence in their ability to
- Identify patients with metastatic NSCLC who may benefit from first-line treatment with immunotherapy combinations
- Identify patients with metastatic NSCLC who may benefit from first-line treatment with immunotherapy combinations
Disclosures
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Faculty
Associate Professor of Medicine
Department of Medical Oncology
Thoracic Unit
Institut Gustave Roussy
Villejuif, France
Editors
Compliance Reviewer
Associate Director, Accreditation and Compliance, Medscape, LLC
Peer Reviewer
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Accreditation Statements
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
For Physicians
Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected].
For Physicians
For ABIM Diplomates
Instructions for Participation & Credit
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
- Read about the target audience, learning objectives, and author disclosures.
- Study the educational content online or print it out.
- Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
